1. Home
  2. CARG vs VRDN Comparison

CARG vs VRDN Comparison

Compare CARG & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$34.23

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$22.96

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
VRDN
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
CARG
VRDN
Price
$34.23
$22.96
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$38.32
$35.46
AVG Volume (30 Days)
828.3K
1.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
0.87
N/A
Revenue
$316,861,000.00
$5,706,000.00
Revenue This Year
$13.89
$13.73
Revenue Next Year
$8.91
$279.00
P/E Ratio
$39.80
N/A
Revenue Growth
59.92
N/A
52 Week Low
$26.39
$13.18
52 Week High
$41.22
$34.29

Technical Indicators

Market Signals
Indicator
CARG
VRDN
Relative Strength Index (RSI) 40.49 54.81
Support Level $32.67 $21.62
Resistance Level $36.46 $24.86
Average True Range (ATR) 1.10 0.80
MACD -0.39 -0.28
Stochastic Oscillator 8.38 37.65

Price Performance

Historical Comparison
CARG
VRDN

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.

Share on Social Networks: